Cargando…

The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum

BACKGROUND: Waterborne cryptosporidiosis is the second cause of diarrhea in young children and immunocompromised hosts after rotavirus. Except for nitazoxanide (NTZ), there is no accredited cryptosporidiosis treatment to date. Therefore, there is an urgent need to find an effective and safe treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaber, Mona, Galal, Lamia Ahmed A, Farrag, Haiam Mohamed Mahmoud, Badary, Dalia M, Alkhalil, Samia S, Elossily, Nahed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789248/
https://www.ncbi.nlm.nih.gov/pubmed/35087280
http://dx.doi.org/10.2147/IDR.S345789
_version_ 1784639726325596160
author Gaber, Mona
Galal, Lamia Ahmed A
Farrag, Haiam Mohamed Mahmoud
Badary, Dalia M
Alkhalil, Samia S
Elossily, Nahed
author_facet Gaber, Mona
Galal, Lamia Ahmed A
Farrag, Haiam Mohamed Mahmoud
Badary, Dalia M
Alkhalil, Samia S
Elossily, Nahed
author_sort Gaber, Mona
collection PubMed
description BACKGROUND: Waterborne cryptosporidiosis is the second cause of diarrhea in young children and immunocompromised hosts after rotavirus. Except for nitazoxanide (NTZ), there is no accredited cryptosporidiosis treatment to date. Therefore, there is an urgent need to find an effective and safe treatment for cryptosporidiosis. This study aimed to investigate the possible anti-protozoal effects of Syzygium aromaticum (clove) oil, Anethum graveolens (dill) seeds oil, Lactobacillus acidophilus LB, and zinc against Cryptosporidium parvum in comparison to NTZ. METHODS: Besides the negative control, mice from six experimental groups (T1–T6) were infected with Cryptosporidium parvum oocysts. On the seventh day post-infection (PID), mice from five groups were treated for 8 consecutive days with NTZ, clove oil, dill seed oil, Lactobacillus acidophilus LB, and zinc commercial forms (T2–T5). Oocysts shedding rate, differences of mice body weight, serum IL10, and TNF-α, cryptosporidial antigen, and cd3 at the intestinal mucosa were evaluated at the end of the experiment. RESULTS: The mean of the C. parvum oocysts’ shedding rate was significantly lower in all treated groups than in the non-treated group. The oocysts reduction rate was the highest in zinc-treated mice (98.3%), Lactobacillus acidophilus LB and dill-treated groups (95.77%), and the NTZ-treated group (91.55%). Clove oil was the least effective, with a 74.65% reduction rate. Excluding the clove oil-treated group, immunohistochemical analysis revealed the clearance of the Cryptosporidium antigen in the intestinal tissue in all treated groups. CONCLUSION: The study has provided a rational basis for using these safe, cheap, and commercially available alternatives in treating cryptosporidiosis combined with NTZ.
format Online
Article
Text
id pubmed-8789248
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87892482022-01-26 The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum Gaber, Mona Galal, Lamia Ahmed A Farrag, Haiam Mohamed Mahmoud Badary, Dalia M Alkhalil, Samia S Elossily, Nahed Infect Drug Resist Original Research BACKGROUND: Waterborne cryptosporidiosis is the second cause of diarrhea in young children and immunocompromised hosts after rotavirus. Except for nitazoxanide (NTZ), there is no accredited cryptosporidiosis treatment to date. Therefore, there is an urgent need to find an effective and safe treatment for cryptosporidiosis. This study aimed to investigate the possible anti-protozoal effects of Syzygium aromaticum (clove) oil, Anethum graveolens (dill) seeds oil, Lactobacillus acidophilus LB, and zinc against Cryptosporidium parvum in comparison to NTZ. METHODS: Besides the negative control, mice from six experimental groups (T1–T6) were infected with Cryptosporidium parvum oocysts. On the seventh day post-infection (PID), mice from five groups were treated for 8 consecutive days with NTZ, clove oil, dill seed oil, Lactobacillus acidophilus LB, and zinc commercial forms (T2–T5). Oocysts shedding rate, differences of mice body weight, serum IL10, and TNF-α, cryptosporidial antigen, and cd3 at the intestinal mucosa were evaluated at the end of the experiment. RESULTS: The mean of the C. parvum oocysts’ shedding rate was significantly lower in all treated groups than in the non-treated group. The oocysts reduction rate was the highest in zinc-treated mice (98.3%), Lactobacillus acidophilus LB and dill-treated groups (95.77%), and the NTZ-treated group (91.55%). Clove oil was the least effective, with a 74.65% reduction rate. Excluding the clove oil-treated group, immunohistochemical analysis revealed the clearance of the Cryptosporidium antigen in the intestinal tissue in all treated groups. CONCLUSION: The study has provided a rational basis for using these safe, cheap, and commercially available alternatives in treating cryptosporidiosis combined with NTZ. Dove 2022-01-20 /pmc/articles/PMC8789248/ /pubmed/35087280 http://dx.doi.org/10.2147/IDR.S345789 Text en © 2022 Gaber et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gaber, Mona
Galal, Lamia Ahmed A
Farrag, Haiam Mohamed Mahmoud
Badary, Dalia M
Alkhalil, Samia S
Elossily, Nahed
The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum
title The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum
title_full The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum
title_fullStr The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum
title_full_unstemmed The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum
title_short The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum
title_sort effects of commercially available syzygium aromaticum, anethum graveolens, lactobacillus acidophilus lb, and zinc as alternatives therapy in experimental mice challenged with cryptosporidium parvum
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789248/
https://www.ncbi.nlm.nih.gov/pubmed/35087280
http://dx.doi.org/10.2147/IDR.S345789
work_keys_str_mv AT gabermona theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT galallamiaahmeda theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT farraghaiammohamedmahmoud theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT badarydaliam theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT alkhalilsamias theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT elossilynahed theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT gabermona effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT galallamiaahmeda effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT farraghaiammohamedmahmoud effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT badarydaliam effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT alkhalilsamias effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum
AT elossilynahed effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum